Supreme Court: Want post-expiration royalties? Go to Congress

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Supreme Court: Want post-expiration royalties? Go to Congress

The US Supreme Court has upheld the ban on royalty payments for sales made after a patent’s expiration

Kimble v Marvel involves Stephen Kimble's invention (patent no 5,072,856) for a toy glove that allows the user to shoot foam string from the wrist. A Marvel predecessor licensed the patent for use in a Spiderman toy. The agreement had no limitation regarding the patent’s expiration. Marvel later sought a declaratory judgment ruling that it was not required to pay royalties for post-expiration sales due to the Supreme Court’s ruling in Brulotte v Thys, which bars such payments. Both the District Court and the Ninth Circuit found in favour of Marvel.

In a 6-3 decision, the Court affirmed, finding that its earlier holding expressly barred patentees from continuing to receive royalties for sales made after the patent has expired. The majority decision written by Justice Kagan held that stare decisis dictates that the Court follow the Brulotte ruling. The majority noted that while Kimble may have raised valid arguments attacking the economic underpinnings behind Brulotte, such arguments should be brought to Congress, not the court.

Similarly, the majority said that Kimble’s proposed alternative, applying the “rule of reason” analysis from antitrust law, would lead to less certainty and higher litigation costs in contrast to the bright-line Brulotte rule.

The majority also found that, despite complaints that the Brulotte prohibition restricts innovation and deal-making, there are multiple ways of drafting agreements that get around this restriction.

The dissent, written by Justice Alito and joined by Chief Justice Roberts and Justice Thomas, argued that though the majority hangs its decision on stare decisis, the underlying Brulotte decision was an example of judicial overreach that was less about interpreting the Patent Act and more about concocting policy. Alito also argued that the policy goals behind Brulotte have been “soundly refuted” and that the bar against royalties for post-expiration sales restricts parties from efficiently structuring agreements to reflect the risk of certain types of research.

Check back later in the week for in-depth analysis of this decision. For Managing IP’s coverage of the oral arguments, click here.

more from across site and SHARED ros bottom lb

More from across our site

The firm reveals how its litigation strategies informed the arguments that took Masimo’s judgment past $818 million
The firm was rebuilding its IP practice through a string of patent hires and a Texas expansion, but its dissolution has put the newly built talent back into the market
AI can exploit longstanding gaps in copyright protection at remarkable speed, but EU law still provides tools to fight back, says Simon Hembt at Bird & Bird
The firm has tapped a local patent trio to establish a foothold in the market and broaden its national presence
New Asia-Pacific IP head Jonathan Chu is eyeing opportunities arising from Chinese technology licensing, overseas enforcement and increasingly IP-heavy cross-border deals
Europe’s largest intellectual property convention and trade fair is back: IP Service World 2026 takes place in Munich from November 23–25 – the 16th edition, with 1,400-plus attendees from 55-plus nations, 100-plus speakers, and 100-plus exhibitors. Three days. Two focused areas. One IP marketplace.
Mehmet Gün and Uğur Aktekin discuss four decades of change in Türkiye’s legal market, the firm’s commitment to independence and the challenge of building an institution that can outlast its founders
Boehringer Ingelheim has instructed a team from Kirkland, while Teva is being represented by Pinsent Masons
The Delhi High Court’s latest directions offer an opportunity to move beyond remedies against bad-faith registrations and address how suspicious applications are identified in the first place, says Fatima Baig at Lexlinc
Camilla Hamrin describes how the acquisition by Acapo Onsagers will impact Bergenstråhle’s trademark practice – and reflects on changes she has seen over 30 years in IP
Gift this article